Related Experiment Video
Updated: Jun 10, 2026
08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
[New insights into acute lymphoblastic leukemia]
Judith Landman-Parker1, Perle Pagès, Arnaud Petit
1Hématologie et Oncologie Pédiatrique, Hôpital Armand Trousseau, 26 avenue du Dr A. Netter, 75571 Paris cedex 12. judith.landman-parker@trs.aphp.fr
Bulletin De L'Academie Nationale De Medecine
|July 31, 2010
Summary
Recent advances in acute lymphoblastic leukemia (ALL) research reveal key insights into leukemic cell maturation arrest, gene mutations, and cell homing. This understanding opens new therapeutic avenues for targeting ALL.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
- Genomics
Context:
- Acute lymphoblastic leukemia (ALL) is a significant hematologic malignancy originating from lymphoid progenitor cells.
- Progress in understanding ALL pathogenesis has been driven by innovations in molecular technologies and genomic analyses.
Purpose:
- To review recent advancements in the comprehension of ALL.
- To highlight key areas including leukemic cell maturation arrest, genetic alterations, chemokine involvement, and lymphoid cell homing mechanisms.
Summary:
- Discusses the molecular basis of maturation arrest in leukemic cells.
- Details initial and acquired genetic defects and chromosomal rearrangements characteristic of ALL.
- Explores the functional role of chemokines in regulating leukemic cell trafficking and localization.
- Elucidates the process of lymphoid cell homing in the context of ALL.
Impact:
- These molecular and cellular insights provide a foundation for developing novel therapeutic strategies.
- Identifies new targets for the precise and effective treatment of acute lymphoblastic leukemia.
